Board Meeting22 Jun 2026, 05:00 pm

Dr Reddy's Board Meeting on July 22, 2026 for Q1 FY27 Results

AI Summary

Dr Reddy's Laboratories Ltd has announced that its Board of Directors will convene on July 22, 2026. The primary agenda item is to consider and approve the Un-audited Standalone and Consolidated Financial Results for the first quarter ending June 30, 2026. Additionally, the company has informed that the trading window for its securities will be closed from June 24, 2026, to July 24, 2026, inclusive, in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015.

Key Highlights

Board meeting scheduled for July 22, 2026.
To approve Q1 FY27 Un-audited Standalone & Consolidated Results.
Trading window closed from June 24 to July 24, 2026.
Compliance with SEBI Listing Obligations and Insider Trading Regulations.

View BSE Filing

DRREDDY

Pharmaceuticals

DR.REDDY'S LABORATORIES LTD.

Price Impact